Middle East News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.

Press releases published on October 19, 2026

Leads Biolabs' Opamtistomig and LBL-034 Featured in Six Abstracts at 2026 ESMO Congress
GTCFX Appoints Charbel Raffoul as CEO, Strengthening Executive Leadership and Global Growth Strategy
Sweet Security Launches Virtual Patching to Protect Production Before Permanent Fixes Are Deployed
VIVUS Announces Positive Outcome of European Procedure to Extend QSIVA® (Phentermine/Topiramate MR) to Adolescents with Obesity
Crypto News: Pepeto Announces AI Tools While Bitcoin Price Targets $1M Per Michael Saylor and Whales Chase Next Dogecoin
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
Indivior to Report Third Quarter 2026 Financial Results
Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
QTREX Regains Compliance with Nasdaq Minimum Bid Price Requirement
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
UroGen Announces FDA Acceptance of the New Drug Application for UGN-103, an Investigational Treatment for Adults with Recurrent LG-IR-NMIBC
Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
Rivus Pharmaceuticals to Present Preclinical Obesity Data for Muscle-Preserving, Oral GLP-1 RV-8451 at ObesityWeek®
Altimmune to Present New Data on Pemvidutide in Serious Liver Diseases at AASLD The Liver Meeting® 2026
COSCIENS ANNOUNCES NEW CORPORATE PRESENTATION AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING
Cormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseases
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at IDWeek 2026
DEEP SEA MINERALS CORP. HIGHLIGHTS U.S. TREASURY RECOGNITION OF DEEP SEA MINING IN CRITICAL MINERALS POLICY AND PROVIDES CORPORATE UPDATE
BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.